Am J Transplant, Volume 17, Suppl 3 Archives - Page 12 of 181 - ATC Abstracts

2017 American Transplant Congress
Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.
E. Giorgakis,¹ R. Heilman,² H. Khamash,² B. Kaplan,² A. Moss,¹ M. Smith,³ K. Reddy.¹
¹Department of Surgery, Mayo Clinic, Phoenix, AZ; ²Department of Medicine, Mayo Clinic, Phoenix, AZ; ³Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
Purpose of the study was to explore the effect of admit AKI donor creatinine on graft outcomes.Method: Single center retrospective analysis of kidney transplants performed…
2017 American Transplant Congress
Screening and Referral of High Risk Liver Transplant Recipients to a Transitional Care Coordination (TCC) Program to Reduce Hospital Readmissions.
A. Masoumi,¹ J. Krzyzewski,¹ T. Stern,¹ N. Schluterman,² D. Bruno,² J. Bromberg,² R. Barth,² S. Hanish.²
¹University of Maryland Medical Center, Baltimore, MD; ²University of Maryland School of Medicine, Baltimore, MD
Introduction One-fifth of Medicare patients are readmitted to the hospital. The readmission rate among liver transplant recipients at a large tertiary academic medical center in…
2017 American Transplant Congress
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.
A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
¹Epidemiology, Johns Hopkins University, Baltimore, MD; ²Surgery, Johns Hopkins University, Baltimore, MD; ³Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD
INTRODUCTION. Few objective tests can be easily performed prior to kidney transplantation (KT) to effectively stratify patients by risk of post-KT mortality. The short physical…
2017 American Transplant Congress
EXPANDER-1: Exploring Renal Transplants Using Hepatitis-C Infected Donors for HCV-Negative Recipients.
C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, M. Bowring, A. Massie, S. Rasmussen, J. Sugarman, D. Segev, M. Sulkowski, N. Desai.
JHU, Baltimore, MD
Kidneys from hepatitis C-infected (HCV+) donors are underutilized in an era of severe organ shortage. In an effort to expand the donor pool, we evaluated…
2017 American Transplant Congress
TACI Polymorphisms Associated with De Novo Alloantibodies in Humans and Allograft Rejection in Mice.
J. Platt,¹ E. Farkash,² A. Lefferts,¹ M. Samaniego,³ M. Cascalho.¹
¹Surgery, University of Michigan, Ann Arbor, MI; ²Pathology, University of Michigan, Ann Arbor, MI; ³Internal Medicine, University of Michigan, Ann Arbor, MI
A. Trans-membrane Activator and CAML Interactor (TACI) controls B cell differentiation and memory and exists as numerous allelic variants among healthy individuals and individuals with…
2017 American Transplant Congress
Minimal Effect of Broader Heart Sharing on Regional Outcomes.
A. Bitar,¹ M. Skeans,² R. Davies,³ M. Farr,⁴ A. Kao,⁵ L. Robbins-Callahan,⁶ J. Rogers,⁷ S. Silvestry,⁸ M. Colvin.^1,2
¹U of MI, Ann Arbor, MI; ²SRTR, Mpls, MN; ³Nemours/AIDHC, Wilmington, DE; ⁴Columbia U, NY, NY; ⁵Mid-America Heart Inst, KC, MO; ⁶UNOS, Richmond, VA; ⁷Duke U, Durham, NC; ⁸FL Hosp Transplant Inst, Orlando, FL
The OPTN/UNOS Heart Subcommittee proposed a revision to policy 6 (Allocation of Hearts and Heart-Lungs) to better address heart transplant candidate medical urgency. They developed…
2017 American Transplant Congress
Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies.
S. Parajuli, P. Reville, T. Ellis, A. Djamali, D. Mandelbrot.
University of Wisconsin, Madison, WI
There is limited information about the role of protocol kidney biopsies for de-novo donor specific antibodies (dnDSA) in kidney transplant recipients (KTR). We initiated monitoring…
2017 American Transplant Congress
HLA-C Mismatching and Humoral Alloimmune Responses in Pediatric Kidney Recipients with Subclinical Vascular Injury.
M. Seifert, M. Yanik, V. Hauptfeld-Dolejsek, R. Mannon.
University of Alabama at Birmingham, Birmingham, AL
Background: Antibodies to mismatched donor HLA antigens (DSA) have been associated with poor long-term outcomes in adult kidney recipients. We recently demonstrated a high prevalence…
2017 American Transplant Congress
High Regulatory T Cells Rate Early After Lung Transplantation Is Associated with Bronchiolitis Obliterans Syndrome Development.
M. Durand,^1,2 P. Lacoste,^2,3 C. Brosseau,^1,3 E. Durand,³ J. Loy,³ K. Henrio,^2,3 R. Danger,¹ P. Royer,³ A. Fourreau,³ A. Magnan,^3,4 S. Brouard.¹
¹INSERM U 1064, Center for Research in Transplantation and Immunology (CRTI), Nantes, France; ²Université de Nantes, Nantes, France; ³UMR INSERM 1087 CNRS 6291, Institut du Thorax, Nantes, France; ⁴Service de Pneumologie, Institut du Thorax, Nantes, France
Despite treatment improvement, the bronchiolitis obliterans syndrome (BOS) affects more than 50% of the lung-transplant recipient in the 5 years post-transplantation and because it cannot…
2017 American Transplant Congress
Living and Deceased Donor Uterus Transplantation – The 2-Arm Czech Uterus Transplant Trial: The First Year Report with Four Cases Done so Far.
J. Fronek,¹ R. Chmel,² L. Janousek,¹ M. Novackova,² J. Matecha,² M. Olausson.³
¹Transplant Surgery Department, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic; ²Gynecology Department, University Motol Hospital, Prague, Czech Republic; ³Department of Surgery, Sahlgrenska University, Goteborg, Sweden
Introduction: Uterus transplantation (UTx) may become another organ transplantation. There is very limited worldwide experience so far. The Czech uterus transplant trial started in 2015.…